Outcomes from a prospectively implemented protocol using apixaban after robot‐assisted radical cystectomy

Abstract

Prophylaxis with apixaban and enoxaparin showed no statistically significant differences in VTE rates among RARC patients. Apixaban appears to be safe and effective for VTE prophylaxis after RARC.